A Phase 1/2 Dose-Escalation and Dose-Randomized, Masked Expansion Trial of Intravitreal 4D-150 Gene Therapy in Adults with Neovascular (Wet) Age-Related Macular Degeneration

Administered By

Awarded By

Contributors

Start/End

  • August 2, 2021 - December 31, 2025